Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

MicroRNA expression profiles in umbilical cord blood cell lineages

M. Merkerova, A. Vasikova, M. Belickova, H. Bruchova

. 2010 ; 19 (1) : 17-26.

Language English Country United States

Document type Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, Validation Study

Grant support
NR9236 MZ0 CEP Register

MicroRNAs (miRNAs), important regulators of cellular processes, show specific expression signatures in different blood cell lineages and stages of hematopoietic stem cell (HSC) differentiation, indicating their role in the control of hematopoiesis. Because neonatal blood displays various features of immaturity, we might expect differential miRNA regulation. Herein, we determined miRNA expression profiles of umbilical cord blood (UCB) cell lineages and compared them to those of bone marrow (BM) and peripheral blood (PB) cell counterparts. Further, we determined mRNA expression profiles using whole-genome microarrays. An approach combining bioinformatic prediction of miRNA targets with mRNA expression profiling was used to search for putative targets of miRNAs with potential functions in UCB. We pointed out several differentially expressed miRNAs and associated their expression with the target transcript levels. miR-148a expression was suppressed in HSCs and its level inversely correlated with the previously verified target, DNA methyltransferase 3B, suggesting dependence of de novo DNA methylation in HSCs on miR-148a. Prolonged cell survival of UCB HSCs may be associated with low expression of miR-143 and miR-145 and up-regulation of their downstream targets (high expression of c-MYC and miR-17-92 and following repression of TGFBR2). In HSCs, we monitored significant up-regulation of eight miRNAs, which were previously verified as regulators of HOX genes. Further, miR-146b may be associated with immaturity of neonatal immune system because it is strongly up-regulated in UCB granulocytes and T lymphocytes compared to PB cell counterparts. Comparative analysis revealed 13 miRNAs significantly altered between UCB and BM CD34(+) cells. In UCB CD34(+) cells, we monitored up-regulation of miR-520h, promoting differentiation of HSCs into progenitor cells, and reduction of miR-214, whose expression might support HSC survival. In conclusion, UCB cells show specific miRNA expression patterns, indicating different regulation in these cells.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12025575
003      
CZ-PrNML
005      
20221005161810.0
007      
ta
008      
120816s2010 xxu f 000 0#eng||
009      
AR
024    7_
$a 10.1089/scd.2009.0071 $2 doi
035    __
$a (PubMed)19435428
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Dostálová, Michaela $7 xx0164071 $u Institute of Hematology and Blood Transfusion, Department of Molecular Genetics, Prague, Czech Republic.
245    10
$a MicroRNA expression profiles in umbilical cord blood cell lineages / $c M. Merkerova, A. Vasikova, M. Belickova, H. Bruchova
520    9_
$a MicroRNAs (miRNAs), important regulators of cellular processes, show specific expression signatures in different blood cell lineages and stages of hematopoietic stem cell (HSC) differentiation, indicating their role in the control of hematopoiesis. Because neonatal blood displays various features of immaturity, we might expect differential miRNA regulation. Herein, we determined miRNA expression profiles of umbilical cord blood (UCB) cell lineages and compared them to those of bone marrow (BM) and peripheral blood (PB) cell counterparts. Further, we determined mRNA expression profiles using whole-genome microarrays. An approach combining bioinformatic prediction of miRNA targets with mRNA expression profiling was used to search for putative targets of miRNAs with potential functions in UCB. We pointed out several differentially expressed miRNAs and associated their expression with the target transcript levels. miR-148a expression was suppressed in HSCs and its level inversely correlated with the previously verified target, DNA methyltransferase 3B, suggesting dependence of de novo DNA methylation in HSCs on miR-148a. Prolonged cell survival of UCB HSCs may be associated with low expression of miR-143 and miR-145 and up-regulation of their downstream targets (high expression of c-MYC and miR-17-92 and following repression of TGFBR2). In HSCs, we monitored significant up-regulation of eight miRNAs, which were previously verified as regulators of HOX genes. Further, miR-146b may be associated with immaturity of neonatal immune system because it is strongly up-regulated in UCB granulocytes and T lymphocytes compared to PB cell counterparts. Comparative analysis revealed 13 miRNAs significantly altered between UCB and BM CD34(+) cells. In UCB CD34(+) cells, we monitored up-regulation of miR-520h, promoting differentiation of HSCs into progenitor cells, and reduction of miR-214, whose expression might support HSC survival. In conclusion, UCB cells show specific miRNA expression patterns, indicating different regulation in these cells.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a antigeny CD34 $x metabolismus $7 D018952
650    _2
$a krevní buňky $x metabolismus $x fyziologie $7 D001773
650    _2
$a buněčný rodokmen $x genetika $7 D019070
650    _2
$a shluková analýza $7 D016000
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fetální krev $x cytologie $x metabolismus $7 D005312
650    _2
$a stanovení celkové genové exprese $7 D020869
650    _2
$a hematopoetické kmenové buňky $x metabolismus $7 D006412
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikro RNA $x genetika $x metabolismus $7 D035683
650    _2
$a lidé středního věku $7 D008875
650    _2
$a sekvenční analýza hybridizací s uspořádaným souborem oligonukleotidů $7 D020411
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a validační studie $7 D023361
700    1_
$a Vašíková, Alžběta $7 xx0126216
700    1_
$a Beličková, Monika $7 xx0099634
700    1_
$a Votavová, Hana $7 xx0081900
773    0_
$w MED00162608 $t Stem cells and development $x 1557-8534 $g Roč. 19, č. 1 (2010), s. 17-26
856    41
$u https://doi.org/10.1089/scd.2009.0071 $y plný text volně přístupný
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20221005161805 $b ABA008
999    __
$a ok $b bmc $g 947617 $s 782921
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 19 $c 1 $d 17-26 $i 1557-8534 $m Stem cells and development $n Stem Cells Dev $x MED00162608
GRA    __
$a NR9236 $p MZ0
LZP    __
$a Pubmed-20120816/10/02

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...